Chloroquine-induced nitric oxide: New treatment for an emerging epidemic of obesity-related glomerulopathy

Diabetes Technology and Therapeutics

Volumn 8, Issue 6, 2006, Pages 691-692

  Osman, M M ^a   Khalil, A ^b   Ahmed, M H ^c  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; HISTAMINE; INSULIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM; VASOPRESSIN;

DRUG EFFECT; DRUG MECHANISM; GLOMERULOPATHY; HUMAN; INSULIN SENSITIVITY; LETTER; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL;

ANTIRHEUMATIC AGENTS; CHLOROQUINE; GLOMERULONEPHRITIS; HUMANS; NITRIC OXIDE; OBESITY;

EID: 33845285541     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.8.691     Document Type: Letter

References (13)

1. Wild SH, Byrne CD: The global burden of the metabolic syndrome and its consequences for diabetes and cardiovascular disease. In: Byrne CD, Wild S, eds. Metabolic Syndrome. Chichester, UK: Wiley & Sons Ltd., 2005:1-32.
2. Hall JE: The kidney, hypertension, and obesity. Hypertension 2003;41:625-633.
3. Wesson DE, Kurtzman NA, Frommer JP: Massive obesity and nephrotic proteinuria with a normal renal biopsy. Nephron 1985;40:235-237.
4. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001;59:1498-1509.
5. Gades MD, Van Goor H, Kaysen GA, Johnson PR, Horwitz BA, Stern JS: Brief periods of hyperphagia cause renal injury in the obese Zucker rat. Kidney Int 1999;56:1779-1787.
6. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988;33:667-672.
7. Johnson PR, Stern JS, Horwitz BA, Harris RE Jr, Greene SF: Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia. Am J Clin Nutr 1997;66:890-903.
8. Trujillo J, Ramirez V, Perez J, Torre-Villalvazo I, Torres N, Tovar AR, Munoz RM, Uribe N, Gamba G, Bobadilla NA: Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am J Physiol Renal Physiol 2005;288:108-116.
9. Schmidt RJ, Baylis C: Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 2000;58:1261-1266.
10. Wagner L, Riggleman A, Erdely A, Couser W, Baylis C: Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis. Kidney Int 2002;62:532-536.
11. Ahmed MH, Ashton N, Balment RJ: The effect of chloroquine on renal function and vasopressin secretion: a nitric oxide-dependent effect. J Pharmacol Exp Ther 2003;304:156-161.
12. Ghigo D, Aldieri E, Todde R, Costamagna C, Garbarino G, Pescarmona G, Bosia A: Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells. J Clin Invest 1998;102:595-605.
13. Ahmed MH: Nitric oxide might be involved in the chloroquine-improved insulin sensitivity: old treatment for global danger. Diabetes Res Clin Pract 2006;72:110-111.